Start cervical cancer screening on Saba February 7th 2022, a pilot for population screening for cervical cancer will start on Saba. All women between 30 and 60 years, will be invited to participate in the coming three years.
Over half a million positive COVID-19 tests, more hospital admissions Last week*, 530,015 positive COVID-19 tests were reported to RIVM**. That is an increase of 45% compared to the week before that. The number of new hospital admissions rose by 11% in the past week. ICU admissions rose by 18%.
RIVM involvement in UN/EU missions RIVM-experts from the Environmental Assessment Unit (EAU) have undertaken two missions involving an emergency situation in the Solomon Islands and an environmental assessment in Georgia.
Clinical condition Dutch MERS patients improving The two patients who were diagnosed last week with the MERS coronavirus are now on the mend.
The MERS-coronavirus in the Netherlands As of 13 May 2014, RIVM and Erasmus MC have diagnosed the MERS coronavirus in two Dutch people. The patients are related and were infected during a joint journey to Saudi Arabia.
New assessment framework for leachate water from landfill sites RIVM and ECN have developed an innovative assessment framework for testing the environmental effects on soil and groundwater of leachate water from sustainable landfill sites.
HFC greenhouse gases accumulate in refrigerators and air conditioners Hydrofluorocarbons (HFCs) are potent greenhouse gases used in refrigerators and air conditioners and are released primarily at the end of the life-span of these products.
RIVM participating in European Joint Action on Chronic Diseases The coming year RIVM is going to be collecting good examples of interventions for the prevention of chronic diseases such as cardiovascular disease and type 2 diabetes.
Is screening for sexually transmitted infections as part of HIV care cost-effective in the Netherlands? Routine screening for anorectal chlamydia among HIV-positive men who have sex with men (MSM) could avert further spread of chlamydia and HIV in the total MSM population.